Ente Ospedaliero Ospedali Galliera Di Genova

3 trials 2 recruiting Academic / non-commercial

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

0 Completed trials

3 Countries active

6 Unique IMPs

N/A Results reported

Phase III

Phase II

Phase III: 1 Phase II: 2

Top indications

Lobular breast carcinoma in situ 1 Ovarian cancer stage IV 1 Ovarian cancer stage III 1

Top IMPs

LETROZOLE 1 METFORMIN HYDROCHLORIDE 1

All trials

3 total

Time restricted Eating And Metformin (TEAM) in invasive breast cancer (IBC) or ductal carcinoma in situ (DCIS). A randomized, phase IIb, win… Pending

2024-518402-40-00 Phase II 1 country METFORMIN HYDROCHLORIDE
Letrozole for Estrogen/Progesterone Receptor positive low-grade serous Epithelial ovarian cancer. A randomized phase III trial. LEPRE Trial Recruiting

2024-516874-31-00 Phase III 2 countries LETROZOLE
Randomized double blind phase 2 trial of baby exemestane versus baby tamoxifen in postmenopausal women at high risk for breast cancer Recruiting

2024-520004-26-00 Phase II 2 countries

Showing 1–3 of 3 trials

← All sponsors A–Z